Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pediatrix Medical Group, Inc. Director's Dealing 2014

Oct 31, 2014

31972_dirs_2014-10-31_9e67088f-e5b4-4f6c-8fe1-9e3f742ca659.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDNAX, INC. (MD)
CIK: 0000893949
Period of Report: 2014-10-30

Reporting Person: Lopez-Blanco Vivian (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-10-30 Common Stock S 8800 $60.00 Disposed 75303.24 Direct

Footnotes

F1: Sales of shares were made pursuant to Reporting Person's 10b5-1 trading plan.